{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:21:36Z","timestamp":1790803296992,"version":"4.1.0"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007270","name":"University of Michigan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007270","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-HL167733"],"award-info":[{"award-number":["R01-HL167733"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35-GM127303"],"award-info":[{"award-number":["R35-GM127303"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K08-HL148552"],"award-info":[{"award-number":["K08-HL148552"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-DK128871"],"award-info":[{"award-number":["R01-DK128871"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-DK131787"],"award-info":[{"award-number":["R01-DK131787"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008456","name":"University of Michigan A Alfred Taubman Medical Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008456","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.atherosclerosis.2025.119174","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T21:32:35Z","timestamp":1742679155000},"page":"119174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Functional interrogation of cellular Lp(a) uptake by genome-scale CRISPR screening"],"prefix":"10.1016","volume":"403","author":[{"given":"Taslima G.","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Bragazzi Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinmay","family":"Raut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Burroughs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitarthi S.","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Leix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha N.","family":"Goonewardena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan V.","family":"Smrcka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth K.","family":"Speliotes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7365-1021","authenticated-orcid":false,"given":"Brian T.","family":"Emmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2025.119174_bib1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1699-0463.1963.tb01808.x","article-title":"A new serum type System in man--the Lp System","volume":"59","author":"Berg","year":"1963","journal-title":"Acta Pathol. Microbiol. Scand."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1399-0004.1974.tb00657.x","article-title":"Lp(a) lipoprotein and pre-beta1-lipoprotein in patients with coronary heart disease","volume":"6","author":"Berg","year":"1974","journal-title":"Clin. Genet."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1399-0004.1997.tb04345.x","article-title":"Epidemiology of Lp(a) lipoprotein: its role in atherosclerotic\/thrombotic disease","volume":"52","author":"Djurovic","year":"1997","journal-title":"Clin. Genet."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib4","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/clinchem\/45.7.1039","article-title":"Lipoprotein(a)-cholesterol and coronary heart disease in the framingham heart study","volume":"45","author":"Seman","year":"1999","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib5","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/jama.1996.03540070040028","article-title":"Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study","volume":"276","author":"Bostom","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib6","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/CIRCULATIONAHA.107.715698","article-title":"Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study","volume":"117","author":"Kamstrup","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib7","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2009.801","article-title":"Genetically elevated lipoprotein(a) and increased risk of myocardial infarction","volume":"301","author":"Kamstrup","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1161\/ATVBAHA.120.315291","article-title":"Lp(a) (Lipoprotein[a]) concentrations and incident atherosclerotic cardiovascular disease: new insights from a large national Biobank","volume":"41","author":"Patel","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/clinchem\/hvaa247","article-title":"Lipoprotein(a) and cardiovascular disease","volume":"67","author":"Kamstrup","year":"2021","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib10","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with Lp(a) lipoprotein level and coronary disease","volume":"361","author":"Clarke","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib11","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/ng.3396","article-title":"A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease","volume":"47","author":"Nikpay","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib12","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1001\/jamacardio.2018.1470","article-title":"Association of LPA variants with risk of coronary disease and the implications for lipoprotein(a)-lowering therapies: a mendelian randomization analysis","volume":"3","author":"Burgess","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib13","article-title":"Lipoprotein(a): a genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease: a scientific statement from the American heart association","author":"Reyes-Soffer","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib14","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1161\/ATV.0000000000000147","article-title":"Lipoprotein(a): a genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease: a scientific statement from the American heart association","volume":"42","author":"Reyes-Soffer","year":"2022","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1109034","article-title":"Genetic associations with valvular calcification and aortic stenosis","volume":"368","author":"Thanassoulis","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib16","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1161\/CIRCULATIONAHA.116.026103","article-title":"A replicated, genome-wide significant association of aortic stenosis with a genetic variant for lipoprotein(a): meta-analysis of published and novel data","volume":"135","author":"Cairns","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib17","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCGENETICS.113.000400","article-title":"Lipoprotein(a) levels, genotype, and incident aortic valve stenosis: a prospective Mendelian randomization study and replication in a case-control cohort","volume":"7","author":"Arsenault","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib18","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jacc.2013.09.038","article-title":"Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population","volume":"63","author":"Kamstrup","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib19","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1093\/eurheartj\/ehz310","article-title":"Statin therapy increases lipoprotein(a) levels","volume":"41","author":"Tsimikas","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1172\/JCI115855","article-title":"Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations","volume":"90","author":"Boerwinkle","year":"1992","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib21","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/BF00220066","article-title":"The apolipoprotein (a) gene: a transcribed hypervariable locus controlling plasma lipoprotein (a) concentration","volume":"90","author":"Kraft","year":"1992","journal-title":"Hum. Genet."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib22","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1172\/JCI113093","article-title":"Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma","volume":"80","author":"Utermann","year":"1987","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib23","doi-asserted-by":"crossref","first-page":"9060","DOI":"10.1016\/S0021-9258(17)37076-X","article-title":"Molecular basis for \"null\" lipoprotein(a) phenotypes and the influence of apolipoprotein(a) size on plasma lipoprotein(a) level in the baboon","volume":"269","author":"White","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib24","doi-asserted-by":"crossref","first-page":"32403","DOI":"10.1074\/jbc.271.50.32403","article-title":"The number of identical kringle IV repeats in apolipoprotein(a) affects its processing and secretion by HepG2 cells","volume":"271","author":"Brunner","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib25","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1194\/jlr.M500249-JLR200","article-title":"Lipoprotein [a] is cleared from the plasma primarily by the liver in a process mediated by apolipoprotein [a]","volume":"46","author":"Cain","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib26","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1042\/bj20030932","article-title":"Galactose-specific asialoglycoprotein receptor is involved in lipoprotein (a) catabolism","volume":"376","author":"Hrzenjak","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib27","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0006-291X(81)80179-9","article-title":"Uptake of Lp (a) lipoprotein by cultured fibroblasts","volume":"102","author":"Floren","year":"1981","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib28","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1172\/JCI110896","article-title":"Studies on the role of specific cell surface receptors in the removal of lipoprotein (a) in man","volume":"71","author":"Krempler","year":"1983","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib29","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0022-2275(20)37595-7","article-title":"Interaction of a recombinant form of apolipoprotein[a] with human fibroblasts and with the human hepatoma cell line HepG2","volume":"37","author":"Tam","year":"1996","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib30","doi-asserted-by":"crossref","first-page":"11649","DOI":"10.1074\/jbc.M114.611988","article-title":"Lipoprotein(a) catabolism is regulated by proprotein convertase subtilisin\/kexin type 9 through the low density lipoprotein receptor","volume":"290","author":"Romagnuolo","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib31","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/S0022-2275(20)37140-6","article-title":"Cellular uptake of lipoprotein[a] by mouse embryonic fibroblasts via the LDL receptor and the LDL receptor-related protein","volume":"38","author":"Reblin","year":"1997","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib32","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jacbts.2020.03.008","article-title":"Lipoprotein(a) cellular uptake ex vivo and hepatic capture in vivo is insensitive to PCSK9 inhibition with alirocumab","volume":"5","author":"Chemello","year":"2020","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib33","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1161\/CIRCRESAHA.116.310272","article-title":"Recycling of apolipoprotein(a) after PlgRKT-mediated endocytosis of lipoprotein(a)","volume":"120","author":"Sharma","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib34","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jacbts.2016.06.006","article-title":"PCSK9 modulates the secretion but not the cellular uptake of lipoprotein(a) ex vivo: an effect blunted by alirocumab","volume":"1","author":"Villard","year":"2016","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib35","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1172\/JCI114602","article-title":"Overexpression of human low density lipoprotein receptors leads to accelerated catabolism of Lp(a) lipoprotein in transgenic mice","volume":"85","author":"Hofmann","year":"1990","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib36","article-title":"Surface LDLR is a major receptor for lipoprotein(a) clearance in male mice lacking PCSK9","volume":"1868","author":"Roubtsova","year":"2023","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib37","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1172\/JCI117794","article-title":"The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans","volume":"95","author":"Rader","year":"1995","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib38","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0021-9150(91)90025-X","article-title":"Catabolism of lipoprotein(a) in familial hypercholesterolaemic subjects","volume":"87","author":"Knight","year":"1991","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib39","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0009-3084(94)90142-2","article-title":"Lp(a) catabolism in hypercholesterolaemic individuals","volume":"67\u201368","author":"Knight","year":"1994","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib40","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/sj.ejhg.5200152","article-title":"Concentrations of the atherogenic Lp(a) are elevated in FH","volume":"6","author":"Lingenhel","year":"1998","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib41","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacc.2014.01.063","article-title":"Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation","volume":"63","author":"Alonso","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib42","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/01.ATV.20.2.522","article-title":"Lipoprotein(a) in homozygous familial hypercholesterolemia","volume":"20","author":"Kraft","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib43","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1161\/01.ATV.16.1.129","article-title":"Lp(a) levels and atherosclerotic vascular disease in a sample of patients with familial hypercholesterolemia sharing the same gene defect","volume":"16","author":"Carmena","year":"1996","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib44","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1016\/j.jacc.2020.03.065","article-title":"Ascertainment bias in the association between elevated lipoprotein(a) and familial hypercholesterolemia","volume":"75","author":"Trinder","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib45","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S2213-8587(16)30042-0","article-title":"High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study","volume":"4","author":"Langsted","year":"2016","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib46","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1038\/s41467-018-04668-w","article-title":"Deep coverage whole genome sequences and plasma lipoprotein(a) in individuals of European and African ancestries","volume":"9","author":"Zekavat","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib47","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1194\/jlr.M076232","article-title":"A genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms","volume":"58","author":"Mack","year":"2017","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib48","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1161\/ATVBAHA.120.315300","article-title":"Genome-wide association study and identification of a protective missense variant on lipoprotein(a) concentration: protective missense variant on lipoprotein(a) concentration-brief report","volume":"41","author":"Said","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib49","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1172\/JCI119753","article-title":"The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor","volume":"100","author":"Argraves","year":"1997","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib50","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0014-5793(93)81087-G","article-title":"Heterogeneous lipoprotein (a) size isoforms differ by their interaction with the low density lipoprotein receptor and the low density lipoprotein receptor-related protein\/alpha 2-macroglobulin receptor","volume":"325","author":"Marz","year":"1993","journal-title":"FEBS Lett."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib51","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cmet.2010.09.010","article-title":"Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress","volume":"12","author":"Seimon","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib52","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1194\/jlr.M038877","article-title":"Scavenger receptor-BI is a receptor for lipoprotein(a)","volume":"54","author":"Yang","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib53","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1194\/jlr.M056150","article-title":"Lipoprotein (a) upregulates ABCA1 in liver cells via scavenger receptor-B1 through its oxidized phospholipids","volume":"56","author":"Sharma","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib54","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s11745-014-3941-4","article-title":"Circulating Lp(a):LDL complexes contain LDL molecules proportionate to Lp(a) size and bind to galectin-1: a possible route for LDL entry into cells","volume":"49","author":"Kalaivani","year":"2014","journal-title":"Lipids"},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib55","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pathol.2018.11.003","article-title":"Lipoprotein(a) catabolism: a case of multiple receptors","volume":"51","author":"McCormick","year":"2019","journal-title":"Pathology"},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1009285","article-title":"Genome-scale CRISPR screening for modifiers of cellular LDL uptake","volume":"17","author":"Emmer","year":"2021","journal-title":"PLoS Genet."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2022.100248","article-title":"The small GTPase RAB10 regulates endosomal recycling of the LDL receptor and transferrin receptor in hepatocytes","volume":"63","author":"Khan","year":"2022","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib58","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-95308-9","article-title":"ACE2 protein expression within isogenic cell lines is heterogeneous and associated with distinct transcriptomes","volume":"11","author":"Sherman","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib59","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nmeth.3047","article-title":"Improved vectors and genome-wide libraries for CRISPR screening","volume":"11","author":"Sanjana","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib60","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.38839","article-title":"The cargo receptor SURF4 promotes the efficient cellular secretion of PCSK9","volume":"7","author":"Emmer","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010377","article-title":"Identification of cell type specific ACE2 modifiers by CRISPR screening","volume":"18","author":"Sherman","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib62","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1186\/s13059-014-0554-4","article-title":"MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens","volume":"15","author":"Li","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib63","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/pro.4218","article-title":"PANTHER: making genome-scale phylogenetics accessible to all","volume":"31","author":"Thomas","year":"2022","journal-title":"Protein Sci."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib64","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib65","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib66","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/s41586-021-04103-z","article-title":"Exome sequencing and analysis of 454,787 UK Biobank participants","volume":"599","author":"Backman","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib67","article-title":"Open-source mapping and variant calling for large-scale NGS data from original base-quality scores","volume":"2020.2012.2015","author":"Krasheninina","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib68","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/s41588-021-00885-0","article-title":"Advancing human genetics research and drug discovery through exome sequencing of the UK Biobank","volume":"53","author":"Szustakowski","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib69","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib70","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/s41588-021-00870-7","article-title":"Computationally efficient whole-genome regression for quantitative and binary traits","volume":"53","author":"Mbatchou","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib71","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ajhg.2014.01.009","article-title":"Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks","volume":"94","author":"Peloso","year":"2014","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/ph15121573","article-title":"Targeted treatment against lipoprotein (a): the coming breakthrough in lipid lowering therapy","volume":"15","author":"Sosnowska","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib73","doi-asserted-by":"crossref","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","article-title":"ClinVar: public archive of relationships among sequence variation and human phenotype","volume":"42","author":"Landrum","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib74","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.gim.2021.09.012","article-title":"The clinical genome Resource (ClinGen) familial hypercholesterolemia variant curation expert panel consensus guidelines for LDLR variant classification","volume":"24","author":"Chora","year":"2022","journal-title":"Genet. Med."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib75","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41588-023-01625-2","article-title":"Comprehensive genetic study of the insulin resistance marker TG:HDL-C in the UK Biobank","volume":"56","author":"Oliveri","year":"2024","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib76","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41586-023-06045-0","article-title":"A genomic mutational constraint map using variation in 76,156 human genomes","volume":"625","author":"Chen","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib77","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/S0040-4039(98)02695-1","article-title":"4-Sulfotetrafluorophenyl (STP) esters: new water-soluble amine-reactive reagents for labeling biomolecules","volume":"40","author":"Gee","year":"1999","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib78","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1194\/jlr.M028563","article-title":"Molecular characterization of proprotein convertase subtilisin\/kexin type 9-mediated degradation of the LDLR","volume":"53","author":"Wang","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib79","doi-asserted-by":"crossref","first-page":"8279","DOI":"10.1074\/jbc.M112.421370","article-title":"Low density lipoprotein binds to proprotein convertase subtilisin\/kexin type-9 (PCSK9) in human plasma and inhibits PCSK9-mediated low density lipoprotein receptor degradation","volume":"288","author":"Kosenko","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib80","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abj8670","article-title":"Cold shock domain-containing protein E1 is a posttranscriptional regulator of the LDL receptor","volume":"14","author":"Smith","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib81","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-3-031-52193-5_6","article-title":"Protein-protein binding kinetics by biolayer interferometry","volume":"3234","author":"Santos-Lopez","year":"2024","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib82","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/01.ATV.13.7.1101","article-title":"Interaction of Lp(a) and of apo(a) with liver cells","volume":"13","author":"Kostner","year":"1993","journal-title":"Arterioscler. Thromb."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib83","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1161\/01.ATV.14.5.770","article-title":"Binding and degradation of lipoprotein(a) and LDL by primary cultures of human hepatocytes. Comparison with cultured human monocyte-macrophages and fibroblasts","volume":"14","author":"Snyder","year":"1994","journal-title":"Arterioscler. Thromb."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2024.117741","article-title":"Biolayer interferometry and its applications in drug discovery and development","volume":"176","author":"Jug","year":"2024","journal-title":"TrAC, Trends Anal. Chem."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib85","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/heart.89.8.893","article-title":"Long term statin treatment reduces lipoprotein(a) concentrations in heterozygous familial hypercholesterolaemia","volume":"89","author":"van Wissen","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib86","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.atherosclerosis.2019.07.021","article-title":"Statins and Lp(a): the plot thickens","volume":"289","author":"Enkhmaa","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib87","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1161\/CIRCRESAHA.118.311227","article-title":"PCSK9: from basic science discoveries to clinical trials","volume":"122","author":"Shapiro","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib88","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1093\/eurheartj\/ehy122","article-title":"Controlled study of the effect of proprotein convertase subtilisin-kexin type 9 inhibition with evolocumab on lipoprotein(a) particle kinetics","volume":"39","author":"Watts","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154221","article-title":"PCSK9 Inhibition with alirocumab increases the catabolism of lipoprotein(a) particles in statin-treated patients with elevated lipoprotein(a)","volume":"107","author":"Watts","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib90","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1194\/jlr.P065334","article-title":"PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's role","volume":"57","author":"Raal","year":"2016","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib91","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jprot.2016.01.016","article-title":"In-depth quantitative analysis and comparison of the human hepatocyte and hepatoma cell line HepG2 proteomes","volume":"136","author":"Wisniewski","year":"2016","journal-title":"J. Proteonomics"},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib92","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.cels.2017.11.002","article-title":"Systems pharmacology dissection of cholesterol regulation reveals determinants of large pharmacodynamic variability between cell lines","volume":"5","author":"Blattmann","year":"2017","journal-title":"Cell Syst"},{"key":"10.1016\/j.atherosclerosis.2025.119174_bib93","article-title":"Systematic elucidation of genetic mechanisms underlying cholesterol uptake","volume":"3","author":"Hamilton","year":"2023","journal-title":"Cell Genom"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025000723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025000723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:31:34Z","timestamp":1762187494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915025000723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":93,"alternative-id":["S0021915025000723"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.119174","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.05.11.593568","asserted-by":"object"}]},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional interrogation of cellular Lp(a) uptake by genome-scale CRISPR screening","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.119174","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"119174"}}